ArticleFrontiers in immunology2025

Case Report: Subcutaneous ofatumumab for patients with immunosuppressant-dependent or ineffective primary membranous nephropathy.

Jie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.